Latest Breaking News On - Md cleveland clinic foundation - Page 1 : vimarsana.com

African Countries Need Help to Boost CV Research

Cardiology research is losing out on a large, diverse, treatment-naive population that could advance science, authors contend.

RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years

The findings might not be generalizable given a high exclusion rate, variations in practice, and statistical issues, experts say.

'Home Time' Validated as TAVI Outcomes Performance Metric

Patients who were alive and well at home in the first 30 days had lower mortality and readmission than those with longer stays.

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate

February 26, 2021 Giving potent antiplatelets up front to ACS patients, regardless of whether they may require CABG, could provide a survival benefit through early induction of platelet quiescence, according to results of a meta-analysis. Senior study author Derek So, MD (University of Ottawa Heart Institute, Ontario, Canada), said the results build on data from the PLATO and TRITON-TIMI 38 trials, both of which suggested potent antiplatelets could bolster survival. Analysis of those two studies plus eight others found greater mortality overall when patients who were admitted for ACS and then underwent CABG had been given weaker antiplatelet strategies, such as aspirin alone or aspirin and clopidogrel, versus potent strategies like aspirin and P2Y12 inhibitors (OR 1.38; 95% CI 1.03-1.85).